WNK2 and breast cancer: These authors reported that re-expression of this gene in a highly invasive breast cancer cell line augmented the activation of Mitogen-Activated Protein Kinase (MAPK) and Wnt/β-catenin signalling pathways, which promoted breast cancer cell invasiveness, motility and chemoresistance (109).